Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $9
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.
Baird analyst Eric Coldwell maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and lowers the price target from $10 to $9.